30 employees
Fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating multi-functional therapeutics.
2015
$39M
from 1 investors over 1 rounds
Elstar Therapeutics Inc. raised $39M on January 3, 2018
Investors: ATP (Apple Tree Partners)